School of Medicine
Showing 11-20 of 72 Results
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
On Partial Leave from 09/05/2023 To 06/30/2024Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Fateme Nateghi Haredasht
Postdoctoral Scholar, Biomedical Informatics
BioAs a postdoctoral scholar at the Stanford Center for Biomedical Informatics Research, I find myself at the exciting intersection of machine learning and healthcare. My journey began with a PhD in Biomedical Sciences from KU Leuven in Belgium, where I delved into the complexities of machine learning algorithms and their transformative potential in healthcare settings. My research, particularly focused on adapting these algorithms for time-to-event data (a method used for predicting specific events in a patient’s future), has not only been a challenging endeavor but also a deeply fulfilling one.
Now at Stanford, my role involves not just advancing machine learning integration in healthcare, but also collaborating with a diverse team of experts. Together, we're striving to unravel complex healthcare challenges and improve patient outcomes. -
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsConversational AI, Large Language Models, Digital Therapeutics
-
Joel Neal, MD, PhD
Associate Professor of Medicine (Oncology)
Current Research and Scholarly InterestsI am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.